Mayzent is an oral treatment for relapse remitting MS and active secondary progressive MS.
- Family Elder
- Posts: 2903
- Joined: Wed Oct 14, 2009 2:00 pm
Novartis AG has said that a late-stage study has shown the oral, once-daily BAF312 drug, or Siponimod, reduced the risk of disability progression in a severe form of multiple sclerosis...Read more - http://www.ms-uk.org/novartis-announces ... mod-250816
MS-UK - http://www.ms-uk.org/